Nutex Health EV/EBIT NUTX

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2021.

Today, Oct 23, 2026: 3.8×
6-year median: 12.7×
Against its 6-year history: 18th; percentile: 0 is its lowest day, 100 its highest
6-year range: 2.3× to 425×
Peer median: 10.1×

Nutex Health's EV/EBIT is 3.8× as of Oct 23, 2026.

That is below its 6-year median of 12.7×, lower than on 82% of days in the last 6 years.

Over that time it ranged from 2.3× in Sep 2025 to 425× in May 2022.

The median for 10 credit services stocks of a similar size is 10.1×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.8×	2.9×	4.0×
2025	2.9×	2.3×	14.3×
2024	7.1×	4.3×	108×
2023	4.8×	3.4×	26.5×
2022	28.9×	14.1×	425×
2021	19.2×	16.3×	255×

Against its peers

Companies in Financial - Credit Services nearest Nutex Health's size, closest first, today.

Company	EV/EBIT
NUTXNutex Health	3.8×
LQDTLiquidity Services	26.9×
ATLCAtlanticus	10.8×
PGYPagaya Technologies	3.6×
HAPNHappen	n/m
WDWalker & Dunlop	26.3×
JCAPJefferson Capital	8.5×
PWPPerella Weinberg Partners	77.8×
WUWestern Union CO	3.3×
ECPGEncore Capital	9.4×
AGMFederal Agricultural Mortgage	n/m
Peer median	10.1×

Where Nutex Health ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Nutex Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.